Patent intelligence · CA
CA 2421303
NOUVEAUX COMPOSES
NOUVEAUX COMPOSES
Patent details — CA 2421303
- Jurisdiction
- CA
- Status
- expired
- Grant date
- Mar 21, 2002
- Expiration
- Mar 16, 2022
- Applicant
- SMITHKLINE BEECHAM CORP [US]
Quick answer
CA 2421303 (NOUVEAUX COMPOSES) is held by SMITHKLINE BEECHAM CORP [US]. Status: expired. Granted Mar 21, 2002. Expires Mar 16, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SMITHKLINE BEECHAM CORP [US]
- Grant date
- Expiration
- Claims
- —
More from SMITHKLINE BEECHAM CORP [US]
Related pharmaceutical patents in our USPTO index.
-
SA 92120308
تركيبة للاستخدام الموضعي topical composition
expired -
AT E269330
CHEMISCHE VERBINDUNGEN
expired -
EP 1425277
HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG
expired -
SA 91110341
مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus
expired -
HU P0302480
PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
expired -
AT E245157
3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
expired -
HK 1004528
Dentifrice compositions
expired -
HU P0204410
PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
expired
Frequently asked questions
What is US patent 2421303?
CA 2421303 (NOUVEAUX COMPOSES) is held by SMITHKLINE BEECHAM CORP [US]. Status: expired. Granted Mar 21, 2002. Expires Mar 16, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CA 2421303?
SMITHKLINE BEECHAM CORP [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does CA 2421303 expire?
Our index shows an expiration date of Mar 16, 2022 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.